Immutep Limited Alternatives & Competitors
12 companies similar to Immutep Limited — The global leader in developing LAG-3 therapeutics (ASX: IMM, NASDAQ: IMMP)
Companies similar to Immutep Limited
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Apexigen
Creating Transformative Immunotherapies for Patients with Cancer
San Carlos, United States
OSE Immunotherapeutics
Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients
Nantes, France
Track all Immutep Limited competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Coley Pharmaceutical Group
Empowering the immune system to conquer illnesses and boost vaccine efficacy.
Egle Therapeutics
Modulating T-regulatory cells to balance immunity
Paris, France
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
AnaptysBio
Transforming patient health by delivering innovative immunology therapeutics.
San Diego, United States
PIN Pharma
A pioneering biopharmaceutical firm dedicated to creating broad-based immuno-modulatory th...
Primmune Therapeutics
Engaging Innate Immunity to Cure Cancer
San Diego, United States
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
About Immutep Limited
**Immutep Limited** is a late-stage clinical biotechnology company that specializes in developing novel LAG-3 immunotherapies to combat cancer and autoimmune diseases. The company's innovative approach involves leveraging the unique capabilities of Lymphocyte Activation Gene-3 (LAG-3) to modulate the immune response. T...
Immunotherapy, Oncology, Clinical Trials, Autoimmune Diseases, Cancer Therapeutics, Immunostimulatory Factor, Therapeutic Antibody, Immune Response Modulation, Immune Control Mechanism, LAG-3 Agonist, MHC Class II Agonist, ASX Listed Company, NASDAQ Listed Company
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Immutep Limited and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Immutep Limited on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
